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OBJECTIVES The goal of this study was to analyze the genetic disorder of a family with cardiomyopathy,
skin disorder, and woolly hair.
BACKGROUND Arrhythmogenic right ventricular dysplasia (ARVD) is a heart muscle disorder causing
arrhythmia and sudden cardiac death. We report a patient with familial autosomal recessive
ARVD, woolly hair, and a pemphigous-like skin disorder with a new mutation in the
desmoplakin gene.
METHODS Genomic deoxyribonucleic acid was extracted from the patient’s blood and 12 first- and
second-degree family members, and was amplified by polymerase chain reaction. Linkage
analysis with polymorphic microsatellites was performed for 11 genes that code for structural
desmosomal proteins. The genetic locus of the disease in this family was mapped to the
chromosomal region 6p24 that contains the desmoplakin gene. Exons of the desmoplakin
gene were analyzed by single-strand conformational polymorphism and direct sequencing.
Confirmation of the mutation was carried out by restriction enzyme analysis.
RESULTS We identified in the patient a homozygous missense mutation in exon 24 of the desmoplakin
gene, leading to a Gly2375Arg substitution in the C-terminal of the protein where the
binding site to intermediate filaments is located. Eight of 12 family members without hair or
skin abnormalities were heterozygous for this mutation. The remaining 4, as well as 90
unrelated healthy control individuals of the same ethnic origin, were homozygous for the
normal allele.
CONCLUSIONS We have described a new mutation in the desmoplakin gene that causes familial ARVD.
These findings suggest that desmosomal proteins play an important role in the integrity and
function of the myocardium. Dysfunction of these proteins can lead to the development of
cardiomyopathies and arrhythmias. (J Am Coll Cardiol 2003;42:319–27) © 2003 by the
American College of Cardiology Foundation
Arrhythmogenic right ventricular dysplasia (ARVD) is an
idiopathic myocardial disease, characterized by fatty or
fibrofatty replacement of the ventricular myocardium (1–3).
A combined European Society of Cardiology/International
Society and Federation of Cardiology (ESC/ISFC) task
force has proposed diagnostic criteria for ARVD (4);
ARVD is clinically characterized by ventricular arrhythmia
of right ventricular origin (5), sudden death, and, occasion-
ally, right heart failure (1). It is a major cause of sudden
death in the young, especially during physical activity (6,7).
In about one-third of patients, ARVD is familial and
mostly inherited as an autosomal dominant trait, with
incomplete penetrance and variable degrees of clinical ex-
pression (8,9). Autosomal dominant forms of ARVD have
been mapped by linkage analysis to chromosomal loci at
14q23 (10), 1q42 (11), 14q12 (12), 2q32 (13), 3p23 (14),
and 10p12-14 (15). In one of these loci (1q42), mutations in
the cardiac ryanodine receptor gene have been identified
(16). Recently, Rampazzo et al. (17) reported a mutation in
human desmoplakin gene causing a dominant form of
ARVD.
A syndrome of autosomal recessive ARVD, skin disorder,
and woolly hair has been reported in families in the island of
Naxos. Genetic analysis has shown that Naxos disease is
caused by a mutation in the gene for plakoglobin (18,19).
Another familial syndrome affecting heart, skin, and hair
has been described in families from Ecuador. In these
families the heart disease was characterized as dilated
cardiomyopathy of the left ventricle, and the cause is a
recessive mutation in the gene for desmoplakin (20).
Both plakoglobin and desmoplakin are components of
desmosomes (21). Desmosomes are major cell adhesion
junctions prominent in the epidermis and cardiac tissue that
are important for rigidity and strength of cells (21,22). We
identified a new recessive mutation in the desmoplakin gene
leading to a Gly2375Arg substitution in the C-terminal of
the protein, where the binding site to intermediate filaments
(IFs) is located in a family with a syndrome of ARVD,
pemphigous-like skin disorder, and woolly hair.
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METHODS
Subjects and clinical material. The family members stud-
ied are of Muslim-Arab origin from Jerusalem. Detailed
questioning and complete physical examination of 12 avail-
able family members obtained a description of the family
pedigree, manner of inheritance, and clinical features, espe-
cially for skin and hair abnormalities. Resting 12-lead
electrocardiogram (ECG) and two-dimensional transtho-
racic echocardiography was performed on three subjects.
The patient underwent computed tomography (CT) scan
and electrophysiologic study. The diagnosis of ARVD was
based on ESC/ISFC guidelines (4). A dermatopathologist
reviewed slides of a skin biopsy from a deceased affected
sibling, performed during evaluation of skin lesions at the
age of 7 years.
Genetic evaluation. After informed consent, venous blood
samples from the patient and first- and second-degree
family members were taken. Genomic deoxyribonucleic acid
(DNA) was extracted using Puregene kit (Gentra system,
catalog no. D-k50, Minneapolis, Minnesota). Genomic
DNA was also extracted from 90 unrelated individuals from
the same ethnic origin, to serve as controls.
Pedigree analysis of this family with a high rate of
consanguinity suggested an autosomal recessive inheritance.
This allowed performing an efficient homozygosity map-
ping, based on a candidate gene approach (23). The ho-
mozygosity mapping was done in the patient and five
first-degree family members for several suspected genes.
Based on previous studies (19,20), we assumed that a defect
in one of the desmosomal proteins was underlying the
syndrome in the family studied. We constructed haplotypes
using polymorphic microsatellites markers (dinucleotide
[CA] repeats) that, according to known genetic maps
(24,25), are linked to genes, encoding structural desmo-
somal proteins, and known to be expressed in the heart
muscle and skin (22). We looked for homozygosity in the
affected proband as compared with nonaffected siblings.
The selected candidate genes and the informative markers
are listed in Table 1.
Each marker was amplified by polymerase chain reaction
(PCR) in a solution containing PCR buffer 1, 1.5 mM
MgCl, 200 mM—each deoxyribonucleoside triphosphate,
200 ng of template DNA, and 2.5 U of Taq DNA
polymerase. Reaction was done with 30 cycles at 94°C for
30 s, annealing for 60 s at 58°C, and extension at 72°C for
60 s. Primers were designed according to sequence of both
sides of the markers; PCR products were analyzed by
electrophoresis on 8M urea, 8% polyacrylamid gels (500 V,
20 h), and were visualized by silver staining, using the
protocol recommended by Promega (Madison, Wisconsin).
After the linkage analysis, the 24 exons of the desmo-
plakin gene were amplified by PCR. Primers were designed
to amplify the entire coding region of the gene; PCR
products were analyzed by single-strand conformational
polymorphism (SSCP) gel electrophoresis (6% acrylamide,
5% glycerol, 1.5 W, 20 h) and by direct sequencing; PCR
products were also subjected to restriction analysis using
Sma1 restriction enzyme.
In order to examine conservation of this genetic region, a
BLAST search for related proteins was performed with the
deduced protein sequence (CAA19927) against the protein
nonredundant database (26). The results of the search are
available at the BLink (BLAST Link) section of the protein
Table 1. Results of Haplotype Mapping for 11 Genes and 10 Informative Microsatellite Markers for the Patient and First-Degree
Family Members
Gene
Genetic
Locus Marker
No. of
Alleles P M B1 B2 S1 S2 AF
Plakoglobin 17q21 D17S1299 4 2,4 3,4 1,4 2,4 1,3 1,3 1,2
Desmoplakin 6p24 D6S1640 2 1,1 1,2 1,2 1,2 1,2 2,2 1,2
D6S296 3 1,1 1,3 1,3 1,3 1,2 2,3 1,2
Des.mic.1 3 3,3 3,2 3,2 3,2 3,1 1,2 3,1
Des.mic.3 3 1,1 1,2 1,2 1,2 1,3 3,2 1,3
Plakophilin-1 1q32 D1S1723 2 1,2 1,2 1,2 1,1 1,2 1,1 1,1/1,2
Plakophilin-2 12p11 D12S1692 4 3,4 2,4 3,4 1,2 1,4 2,3 1,3
Desmocollin 1–3* 18q12 D18S456 2 1,2 1,2 1,2 1,1 1,2 1,1 1,1/1,2
Desmoglein 1–3* D18S457 2 1,2 1,2 2,2 2,2 2,2 2,2 1,1/1,2
BPAG1 6p11-p12 D6S295 4 1,2 1,4 1,2 1,3 2,4 1,3 2,3
*The interval between the markers D18S456 and D18S457 contains the cluster of six genes: Desmocollin 1,2,3 and Desmoglein 1,2,3.
AF  alleged father; BPAG1  bollous pemphigoid antigen1; B1, B2  brothers; M  mother; P  patient; S1, S2  sisters. Mapping results for the markers linked to
the desmoplakin gene (bolded).
Abbreviations and Acronyms
ARVD  arrhythmogenic right ventricular dysplasia
CT  computed tomography
DNA  deoxyribonucleic acid
ECG  electrocardiogram
ESC/ISFC  European Society of
Cardiology/International Society and
Federation of Cardiology
ICD  implantable cardiac defibrillator
IF  intermediate filament
PCR  polymerase chain reaction
PRD  plakin repeat domain
SSCP  single-strand conformational
polymorphism
VT  ventricular tachycardia
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sequence entry (CAA19927) at the National Center for
Biotechnology Information protein database.
RESULTS
Clinical features. This clinical syndrome consists of sud-
den death with hair and skin abnormalities. Family medical
history was significant for eight members who died suddenly
during young adulthood (ages 15 to 30 years). All of them
had woolly hair and exceptionally dry skin in all parts of the
body beginning at birth. During childhood, they presented
with vesicular lesions on the extremities, particularly on the
knees, palms, and soles. Biopsy from a lesion taken from the
deceased patient’s brother, who died at the age of 23,
demonstrated histology similar to pemphigous foliaceous
(Fig. 1). The affected family members died before we carried
out this study. They did not have major cardiac symptoms
before their sudden death and did not undergo any cardiac
evaluation.
We identified one living affected female with similar skin
and hair abnormalities as described above. She presented
with recurrent syncope at the age of 16. Ventricular tachy-
cardia (VT) of right ventricle origin was documented (Fig.
2). The origin of the VT is in the midseptal area, which is
not the typical origin in ARVD; however, ventricular
arrhythmia can originate from different parts of the right
ventricle in ARVD patients (5). Resting 12-lead ECG
demonstrated T-wave inversion with localized prolongation
of the QRS complex in the right precordial leads (V1 to V3)
and normal QT interval (Fig. 2).
Transthoracic echocardiography (two-dimensional) re-
vealed a mildly dilated right ventricle without regional wall
motion abnormalities or aneurysmatic dilation, a normal left
ventricle, and no significant valvular defects or pulmonary
hypertension; magnetic resonance imaging was not per-
formed because of prior implantable cardiac defibrillator
(ICD) implantation. Cardiac CT scan was not informative
because of artifacts from the ICD electrodes, located in the
right ventricle. Based on the ESC/ISFC criteria (4), a
diagnosis of ARVD was made (one major and four minor
criteria; typical arrhythmia, ECG changes, echocardio-
graphic changes, and family history of sudden death).
Ventricular arrhythmia was not inducible on electrophysi-
ologic study, and the patient was treated with an ICD.
Antiarrhythmic medication was added to prevent recurrent
VT.
No skin and hair abnormalities were found in 12 of the
patient’s first- and second-degree relatives. Cardiac assess-
ment of two heterozygous subjects for the disease mutation
(the patient’s mother and cousin) revealed no abnormalities.
In summary, this family presented with “Naxos-like”
syndrome with ARVD and sudden death, woolly hair, and
pemphigous-like skin disorder. Constructed pedigree (Fig.
3) showed a high rate of consanguinity with various affected
individuals, suggestive of an autosomal-recessive inheritance
pattern. The available heterozygous individuals demon-
strated normal cardiac (two subjects) and skin (eight sub-
jects) phenotype.
Genetic analysis. Haplotyping with 20 microsatellite
markers was performed in the patient, her mother, and four
siblings; eight of them were informative. The results are
summarized in Table 1. Homozygosity in the affected
individual compared with heterozygosity in the unaffected
family members was demonstrated in the marker D6S296,
mapping to chromosomal region 6p24. This marker is
located 0.6cM from the desmoplakin gene. No other genetic
loci showed similar results, and heterozygous state of the
marker alleles in the patient exclude the possibility of a
relevant homozygous mutation in these loci.
Figure 1. Histological section (H & E  40) of skin biopsy taken from the deceased patient’s brother. The histology is compatible with the diagnosis of
pemphigus foliaceous.
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To confirm these findings, two additional microsatellite
markers were genotyped. We chose the markers Des.mic.1
and Des.mic.3 that are located inside the introns of the
desmoplakin gene (20). Haplotyping of these markers dem-
onstrated homozygosity only in the affected individual
(Table 1). These results suggest that the desmoplakin gene
might be the mutated gene in this family.
The desmoplakin gene contains 24 exons and 9,588 bases
messenger ribonucleic acid coding for a 2871 aa protein;
PCR products of all exons were analyzed by SSCP and
direct sequencing. Sequence analysis of exon 24 revealed a
point mutation in position 7402 causing substitution of G in
the wild type to C in the patient leading to a Gly2375Arg
substitution in the protein (Fig. 4). Sequence analysis of the
rest of the gene did not reveal other mutations.
The G2375R mutation in the desmoplakin gene creates a
new recognition site for the restriction enzyme Sma1 that
facilitates rapid screening for the mutation in other family
members. We amplified by PCR a 722 base pair (bp)
fragment from exon 24 of the desmoplakin gene that
contains the mutation. After digestion with Sma1, the
mutant allele was cleaved to two fragments of 365 and 357
bps, while the wild type allele did not. We analyzed the
patient, 12 unaffected family members, and 90 unrelated
control individuals. Only the patient was homozygous for
the mutation, while eight unaffected family members were
heterozygous for the mutation, and the remaining four were
homozygous for the normal allele (Fig. 5). The 90 control
subjects were homozygous for the normal allele (data not
shown), excluding the possibility of a polymorphic site in
the mutation region.
We also examined the conservation of the mutation
genetic region with a blast search (26). The search reveals
that the Homo sapiens desmoplakin I sequence is almost
identical to that of Mus musculus (XP_138583), and signif-
icantly similar to those of Rattus norvegicus (CAA42169)
and Cricetulus griseus (AAF70372) and the available 5
sequence of the Xenopus laevis (AAD48849) gene. In
particular, the region of the described mutation (Fig. 4B) is
highly conserved.
Figure 2. The 12-lead electrocardiogram (ECG) showing the difference between the right leads (V1 to V2) and the left leads (V5 to V6). (A) The ECG.
(B) Detail of V2 and V6 demonstrating a 70-ms wider right-sided QRS compared with the left-sided one. (C) An ECG record of the patient during
ventricular tachycardia (VT). The VT is left bundle branch block QRS configuration with 250-ms cycle length, originating in the right ventricular midseptal
area.
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DISCUSSION
We report a new recessive mutation in the desmoplakin
gene causing familial ARVD, woolly hair, and an epider-
molytic skin disorder. The genetic work-up in this large
family with a high rate of consanguineous marriage utilizes
a strategy of homozygosity mapping to examine loci based
on a candidate gene approach. This efficient method led to
the identification of a new mutation, despite the relatively
small number of analyzed subjects.
The G2375R mutation in the desmoplakin gene creates a
Figure 3. Pedigree of the family studied is characterized by high rates of consanguinity. Circles  females; diagonal lines  deceased; filled  living
affected females; filled with broken line  family members who died suddenly and had skin and hair abnormalities; squares  male.
323JACC Vol. 42, No. 2, 2003 Alcalai et al.
July 16, 2003:319–27 Desmoplakin Mutation, ARVD, and Skin Disorder
new recognition site for the restriction enzyme Sma1. Using
restriction enzyme analysis, we performed rapid screening
for the mutation in the family members, and eight heterozy-
gous subjects were identified. This method can facilitate the
diagnosis of ARVD and genetic counseling in this family.
Mutations in desmosomal proteins causing a syndrome
with cardiac, hair, and skin abnormalities have been de-
scribed. Naxos disease is an autosomal recessive condition
where the phenotype is ARVD, woolly hair, and palmo-
plantar keratoderma, and the affected gene is plakoglobin
Figure 4. (A) The G2375R mutation in the desmoplakin gene (bold) is a g to c substitution. (B) The protein sequence alignment of the mutated region
in the human desmoplakin (HS DSP), in desmoplakin of other species (Mus musculus, Rattus norvegicus and Cricetulus griseus) and in other human plakin
family members (PLE  plectin, EPP  epiplakin, BPA  bullos pemphigoid antigen1). The glycin in position 2375 of the human desmoplakin (bold)
is extremely conserved.
Figure 5. Gel electrophoresis of the mutation containing polymerase chain reaction product after digestion with Sma1. The mutant fragment is cleaved to
two smaller fragments in similar size demonstrated by a single band, 365/357 base pairs (bp). The wild-type fragment is resistant to digestion and
demonstrated by the higher single band, 722 bp.
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(19). Mutations in the desmoplakin gene have been shown
to underlie some cases of the autosomal dominant skin
disorder (striate palmoplantar keratoderma) without cardiac
involvement (28–30), a dominant form of ARVD without
skin disease (17) and an autosomal recessive condition
characterized by dilated cardiomyopathy, woolly hair, and
keratoderma (20). Both desmoplakin and plakoglobin are
important components of desmosomes (22). Desmosomes
are symmetrical disc-shape intracellular junctions found
primarily in epithelial tissue. They mediate adhesion be-
tween cells and link the IFs of neighboring cells, thus
establishing an integrated framework across the entire tissue
(30,31).
Desmoplakin is a member of the plakin family of IF
binding proteins. The primary structure of desmoplakin
contains three functional domains: the N-terminal, which
binds to the desmosome via connection with plakoglobin
and plakophilin; the rod segment, which is predicted to
form a dimeric coil; and the C-terminal domain, which
binds IF’s (32) (Fig. 6). The C-terminal contains three
segments A, B and C; each expresses 4.5 copies of the
plakin repeat domain (PRD). The G in position 2375
resides at the end of PRD3 of segment B and is extremely
conserved among other plakin family members (32). The
PRDs form a globular structure with a basic groove, which
is predicted to represent the IF’s binding site. The crystal
structure of segment B revealed that the Glycine residues at
the end of PRD1 and PRD3 adopt a backbone conforma-
tion only available to the Glycine residue, which produces a
sharp turn. Thus, the mutation described here of substitu-
tion of the Glycine in position 2375 to a positively charge
arginine is very likely to alter the B segment and disrupt the
desmoplakin-IF’s interaction. A similar mechanism was
proposed by Norgett et al. (20) who described a mutation
that causes truncation of desmoplakin and the lack of the C
segment of the IF’s binding site (Fig. 6).
Alternative splicing of the protein produces two isoforms,
desmoplakin I and desmoplakin II, which differ in the
length of the intermediate rod domain (33). The mutations
described are in the N or C terminal of the desmoplakin
(Fig. 6); therefore, they will affect both isoforms.
The pathology of ARVD is characterized by fibrofatty
replacement of right ventricular myocytes (1). The mecha-
nism could be disruption of desmosomal function caused by
a mutated structural protein, such as desmoplakin or plako-
globin. Under conditions of mechanical stress, the desmo-
somal dysfunction can lead to detachment of the myocytes
at the intercalated disc, with progressive myocyte apoptosis
(19,34). As regeneration of cardiac myocytes is limited,
fibrofatty replacement takes place and provides the anatom-
ical basis for progressive cardiac failure, arrhythmia, and
sudden death. Impairment of cell-cell adhesion could also
be a mechanism common to other familial cardiomyopa-
thies (35).
Nonsense mutations leading to desmoplakin haplo insuf-
ficiency caused skin disorders (27–29); mutation in the
N-terminal caused ARVD (17), while mutation in the
C-terminal as described here and by Norgett et al. (20)
caused cardiac, skin, and hair syndrome (Fig. 6). The
genotype-phenotype relationships are subjects for further
investigation.
Defects in desmoplakin, and autoantibodies to desmo-
plakin, have been described in various skin disorders, par-
ticularly palmo-plantar keratodermas (21), skin blistering
Figure 6. Domain structure of desmoplakin and the known mutation. The S229R mutation causes arrhythmogenic right ventricular dysplasia (17); the
Q331X, Q664X, and C809X are nonsense desmoplakin mutations leading to functionally null alleles and cause striate palmoplantar keratoderma in
heterozygotes (28–30). The G2375R and the 7901delG cause cardiomyopathy with skin and hair abnormalities.
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diseases such as autoimmune pemphigous and other
pemphigous-related disorders (36,37). Desmosomal in-
volvement was described in infectious skin diseases as in
bolus impetigo and in staphylococcal scalded-skin syndrome
(38).
In our family the skin disease is characterized clinically
and histologically as the autoimmune blistering skin disease
pemphigous foliaceous. Antibodies to desmoplakin in a
patient with pemphigous foliaceous have been previously
described (37). This finding supports the hypothesis that
this skin disease is a result of dysfunction of the desmosome,
and particularly of the desmoplakin. It is likely that the same
mechanism that causes disruption of IF’s interaction with
the desmosome in the heart muscle impairs binding of
keratin to the desmosome in the epidermis thereby causing
skin lesions under conditions of stress. Areas of the skin that
are less mechanically stressed such as the arm and back
demonstrate normal histology. This theory could underline
the tissue-specific phenotype seen here and in the previously
described desmosomal syndromes, as the heart muscle, and
in some areas in the skin are tissues that are most exposed to
constant mechanical stress.
The large spectrum of skin phenotypes related to dys-
function of the desmosomal and IFs is probably due to
multiple genetic and environmental factors that have yet to
be determined.
The defect in desmoplakin could also lead to fragility at
desmosomal junctions in hair cells leading to hair-shaft
dysplasia that causes the woolly hair phenotype as described
in other desmosomal molecules (22,39).
The major limitation of this study was that we analyzed
only a single patient. Most members of this family reside in
the Palestinian Authority and Jordan. Due to political
unrest in the area, we have been unable to locate and
evaluate other affected family members. Nevertheless, the
possibility that the mutation identified is a rare polymor-
phism rather than a disease-causing mutation is extremely
unlikely. First, we demonstrated homozygosity for the
desmoplakin locus only in the patient. Second, we excluded
the possibility of some other candidate genes to be the
disease-causing gene in this family. Third, the mutation we
found results in a substitution from the highly conserved
glycine residue, which adopts a backbone conformation, to
a positively charged amino acid. This is likely to alter the
configuration of the tail region of the protein. Fourth, by
restriction enzyme analysis in multiple family members and
90 healthy controls, we demonstrated that this Gly2375Arg
substitution exists only in this family and the patient is the
single homozygous, supporting the conclusion that this is a
mutation site rather than a polymorphic site.
Our finding underlines the importance of cellular junc-
tions in maintaining tissue integrity, especially in the heart
and skin. The exact role of desmosomal proteins in the
pathogenesis of heart failure and cardiac arrhythmia will
require further studies.
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